The Easysweet Ecstasy (MDMA) Rapid Test is a rapid, qualitative, competitive binding immunoassay for the specific detection of methylenedioxymethamphetamine (MDMA) metabolites in urine. This test quickly (5 minutes) confirms the presence of MDMA in a subject sample with a minimum cut-off sensitivity level of 500 ng/ml MDMA.
Note: This test only provides preliminary analytical test results. More specific alternative chemical methods such as high pressure liquid chromatography (HPLC) or gas chromatography/mass spectrometry (GC/MS) must be used to obtain confirmatory analytical results.
MDMA is a designer drug first synthesized by a German pharmaceutical company in 1913 to treat obesity. People taking this drug often report adverse reactions, such as muscle tension and sweating. MDMA is clearly not a stimulant, although it, like amphetamines, has the ability to increase blood pressure and heart rate. MDMA does produce some perceptual changes in the form of increased sensitivity to light, difficulty focusing, and blurred vision for some users. Its mechanism of action is thought to be through the release of the neurotransmitter serotonin. MDMA may also release dopamine, although this is generally considered a side effect of the drug. The most prevalent effects of MDMA occur in almost anyone taking reasonable doses of the drug. The MDMA ecstasy test produces a positive result when methylenedioxymethamphetamine in urine exceeds the NIDA standard of 500ng/ml.
The excretion half-life of MDMA metabolized in urine is estimated by different techniques and ranges from 2 to 3 days. The Ecstasy (MDMA) Rapid Test utilizes a unique combination of monoclonal antibodies to selectively identify MDMA metabolites in urine with high sensitivity. The test device is a quick, intuitive screening test that requires no instrumentation and provides a quick indication of recent Ecstasy consumption. Comprehensive information on drug testing, including typical half-life or drug detection periods.
Easysweet Ecstasy (MDMA) Rapid Test
The Easysweet Ecstasy (MDMA) Rapid Test technology incorporates a chromatographic absorption device in which a drug or drug metabolite in the sample competes with MDMA derivatives immobilized on a porous membrane for limited antibody sites. This is the scientific method of choice for qualitative analysis. During the assay, urine is mixed with the labeled antibody-dye conjugate and migrates through the test device. When MDMA levels were below 500 ng/ml (the test's detection cut-off sensitivity), unbound antibody-dye conjugate bound to the immobilized antigen conjugate in the test area ("T"), producing a negative result indicating a negative result. Pink rose ribbon. Conversely, when MDMA levels are above the detection limit, the antibody-dye conjugate binds to the free drug, forming an antigen-antibody-dye complex. This complex competes with the immobilized antigen conjugate in the test zone, preventing the formation of pink rose bands. Regardless of the test results, bands were generated in the control region ("C") by a non-specific sandwich dye conjugation reaction. The band serves as a built-in quality control by demonstrating antibody recognition, verifying the chemical activity of the reagents, and confirming that the test was performed correctly.
Easysweet Ecstasy (MDMA) Rapid Test can quickly detect whether there are drugs in the body. It is suitable for some people who need to confirm whether there are drugs in the body. If you also need this product, you can contact me